Phoenix Financial Ltd. lessened its holdings in shares of Danaher Corporation (NYSE:DHR – Free Report) by 39.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,946 shares of the conglomerate’s stock after selling 3,205 shares during the period. Phoenix Financial Ltd.’s holdings in Danaher were worth $1,133,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of the stock. Enterprise Financial Services Corp raised its position in shares of Danaher by 1.4% in the 4th quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after purchasing an additional 46 shares during the last quarter. Kennebec Savings Bank raised its position in shares of Danaher by 1.4% in the 4th quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock worth $766,000 after purchasing an additional 46 shares during the last quarter. Revolve Wealth Partners LLC raised its position in shares of Danaher by 2.6% in the 4th quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock worth $428,000 after purchasing an additional 47 shares during the last quarter. Kestra Private Wealth Services LLC raised its position in shares of Danaher by 0.3% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after purchasing an additional 48 shares during the last quarter. Finally, Norway Savings Bank raised its position in shares of Danaher by 0.7% in the 4th quarter. Norway Savings Bank now owns 7,063 shares of the conglomerate’s stock worth $1,617,000 after purchasing an additional 49 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Insiders Place Their Bets
In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares in the company, valued at $1,060,642.99. The trade was a 20.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 10.80% of the company’s stock.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Analysis on Danaher
Danaher Price Performance
Shares of NYSE:DHR opened at $161.95 on Friday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The business has a 50-day simple moving average of $186.30 and a two-hundred day simple moving average of $210.38. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The firm has a market cap of $114.62 billion, a price-to-earnings ratio of 31.32, a price-to-earnings-growth ratio of 2.20 and a beta of 0.81.
Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter in the previous year, the firm earned $1.88 EPS. Danaher’s revenue was up 3.7% on a year-over-year basis. On average, analysts expect that Danaher Corporation will post 8.43 earnings per share for the current year.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 1.0%. Danaher’s payout ratio is 30.95%.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
